Healthcare - Biotechnology - NASDAQ - US
$ 0.8335
-3.45 %
$ 38 M
Market Cap
-0.45
P/E
CASH FLOW STATEMENT
-38.6 M
OPERATING CASH FLOW
-362 K
INVESTING CASH FLOW
74.2 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Verrica Pharmaceuticals Inc.
| Net Income | -67 M |
| Depreciation & Amortization | 836 K |
| Capital Expenditures | -362 K |
| Stock-Based Compensation | 14.4 M |
| Change in Working Capital | 9.86 M |
| Others | 14.9 M |
| Free Cash Flow | -38.9 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | |
|---|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | ||||||||
| Net Income | (67.0) | (24.5) | (35.1) | (42.7) | (28.2) | (20.6) | (4.5) | (1.9) |
| Depreciation & Amortization | 0.8 | 0.7 | 0.5 | 0.2 | 0.3 | 20 K | 0 | 0 |
| Deferred Income Tax | 0 | 0 | 66 K | (0.1) | 0 | 0 | 0 | 0 |
| Stock Based Compensation | 14.4 | 5.0 | 6.1 | 9.8 | 3.3 | 2.3 | 82 K | 9 K |
| Other Operating Activities | 3.3 | 1.9 | 1.4 | 0.9 | (1.1) | (0.4) | 18 K | 62 K |
| Change in Working Capital | 9.9 | (1.8) | (0.5) | 1.6 | (1.7) | 0.9 | (0.2) | 0.3 |
| Cash From Operations | (38.6) | (18.6) | (27.6) | (30.2) | (27.4) | (17.9) | (4.6) | (1.6) |
| INVESTING CASH FLOW | ||||||||
| Capital Expenditures | (0.4) | (0.3) | (0.9) | (1.5) | (0.7) | (0.8) | 0 | 0 |
| Other Items | 0 | 54.3 | (0.1) | (2.1) | 26.6 | (79.1) | 0 | 0 |
| Cash From Investing Activities | (0.4) | 54.0 | (1.0) | (3.6) | 26.0 | (79.9) | 0 | 0 |
| FINANCING CASH FLOW | ||||||||
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Debt Repaid | 44.1 | (43.8) | 5.0 | 34.5 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 30.1 | 17 K | 0.6 | 0.8 | 0.4 | 21.0 | 12.7 | 0.5 |
| Cash From Financing Activities | 74.2 | (16.9) | 33.6 | 35.2 | 0.4 | 99.4 | 12.7 | 0.5 |
| CHANGE IN CASH | ||||||||
| Net Change In Cash | 35.3 | 18.5 | 5.1 | 1.4 | (1.0) | 1.6 | 8.1 | (1.1) |
| FREE CASH FLOW | ||||||||
| Free Cash Flow | (38.9) | (19.0) | (28.5) | (31.7) | (28.1) | (18.6) | (4.6) | (1.6) |